Cardiometabolic Health of People with Severe and Persistent Mental Illness

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1111136

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

People with schizophrenia have much higher rates of smoking, obesity and diabetes. To date, psycho-social interventions to reduce these physical health risk factors have had limited success. This research aims to conduct clinical trials among people with schizophrenia of 1. a novel diabetes medication to help people lose weight and gain better control of their sugars, and 2. newly developed vaporised nicotine products to help reduce cigarette smoking.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $187,322.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diabetes mellitus | metabolic syndrome | obesity | schizophrenia and related disorders | smoking intervention

Related Links